Ardigen at AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer

Topic:

Between October 14th and 17th our lead scientist Giovanni Mazzocco attended the 30th Anniversary AACR Special Conference.

The conference titled “Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer” was focused on discussing the power and limitations of computational tools for the analysis of cancer related data.

During those four days we attended sessions, talked to speakers and exhibitors, discussed posters and deepend our knowledge on the intersection between cancer research and data science. This conference gave us the opportunity to hear about the state of the art of cancer research from incident to early diagnosis, prevention, treatment and outcome prediction, with great emphasis on approaches leveraging big data and new computational methods such as machine learning and artificial intelligence.

Please have a look at our blog to read more about our impressions from the meeting.

You might be also interested in:

Poster: Bridging the Phenotype-Proteome Gap: A Multi-Modal AI Framework for analysis of Cell Painting images
Biomedical knowledge graph connecting drug discovery data, disease biology, targets and indications to support target prioritization and indication expansion
Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets
Molecular structure representing AI-supported antibody design for blood-brain barrier research
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
Life sciences conference takeaways 2026 - AACR, PEGS Boston, SLAS Europe, and Bio-IT World summary on AI in drug discovery
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!